US EditionFrench Lab Union Exodus: Major Labs Depart
5 Articles
5 Articles
Fifteen manufacturers, including Sanofi, Ipsen and Pierre Fabre, left the LEEM, the federation of pharmaceutical companies in France, considering that it no longer represents their interests well enough.
Fifteen industrialists announced their decision to leave the historical lobby of the sector, causing an extraordinary board of directors on 8 January. In question, the defence deemed insufficient of the interests of French laboratories by Leem. These departures already augur well for substantial political and financial consequences for the employers' organisation.
On 8 January 2026, the Leem, the leading drug union in France, officially announced their departure from the organisation. The decision, which had been matured for several months according to the stakeholders concerned, revealed deep fractures in the pharmaceutical industry. Leem and the pharmaceutical industry: a divorce between the laboratories and the trade union The rupture between the Leem and several laboratories did not lead to a simple e…
The employer's representation of the pharmaceutical industry in France seems to be at a strange crossroads. By sober press releases and without going into detail, Leem and six of the largest French pharmaceutical laboratories indirectly reported a separation.
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
